Sumatriptan Succinate Transdermal Delivery Systems for The Treatment of Migraine
- 1 June 2008
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 97 (6) , 2102-2109
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Combination strategies for enhancing transdermal absorption of sumatriptan through skinInternational Journal of Pharmaceutics, 2006
- Bioadhesive monolayer film for the in vitro transdermal delivery of sumatriptanJournal of Pharmaceutical Sciences, 2006
- Iontophoretic Transdermal Delivery of Sumatriptan: Effect of Current Density and Ionic StrengthJournal of Pharmaceutical Sciences, 2005
- Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinateEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Penetration enhancersAdvanced Drug Delivery Reviews, 2004
- Iontophoretic drug deliveryAdvanced Drug Delivery Reviews, 2004
- Current options for the prevention and treatment of migraineClinical Therapeutics, 2001
- Triptans in MigraineDrugs, 2000
- Transdermal drug delivery: overcoming the skin’s barrier functionPharmaceutical Science & Technology Today, 2000
- The Relative Effect of Azone® and Transcutol® on Permeant Diffusivity and Solubility in Human Stratum CorneumPharmaceutical Research, 1996